Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoaki Tanaka

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Seikagaku. the Journal of Japanese Biochemical Society|April 23, 2010
[Regulation of p53 function and promoter selectivity by post-translational modifications]Tomoaki Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 12, 2011
[Mechanisms of cellular senescence by tumor suppressor p53]Tomoaki Tanaka
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2011
Quantitative analysis of the enzymes associated with 5-fluorouracil metabolism in prostate cancer biopsiesTomoaki Tanaka
International Journal of Urology : Official Journal of the Japanese Urological Association|October 12, 2019
Editorial Comment from Dr Tanaka to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasiaTomoaki Tanaka
International Journal of Urology : Official Journal of the Japanese Urological Association|June 11, 2014
Editorial comment from Dr Tanaka to Non-bladder conditions in female Taiwanese patients with interstitial cystitis/hypersensitive bladder syndromeTomoaki Tanaka
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|July 23, 2011
[Epigenetic regulation and molecular mechanisms of cellular senescence by tumor suppressor p53]Tomoaki Tanaka, Koutaro Yokote
International Journal of Urology : Official Journal of the Japanese Urological Association|January 16, 2025
Editorial comment on "Dutasteride, a 5 alpha-reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia"Tomoaki Tanaka, Akinori Minami
Journal of Human Genetics|December 9, 2016
Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitusNaoko Hashimoto, Tomoaki Tanaka
Recent Patents on Anti-Cancer Drug Discovery|May 27, 2011
New therapeutic strategies for castration-resistant prostate cancerTomoaki Tanaka, Tatsuya Nakatani
Endocrine Journal|May 28, 2025
Advancing liver metabolic zonation with single-cell and spatial omicsMasanori Fujimoto, Tomoaki Tanaka
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Seikagaku. the Journal of Japanese Biochemical Society|April 23, 2010
[Regulation of p53 function and promoter selectivity by post-translational modifications]Tomoaki Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 12, 2011
[Mechanisms of cellular senescence by tumor suppressor p53]Tomoaki Tanaka
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2011
Quantitative analysis of the enzymes associated with 5-fluorouracil metabolism in prostate cancer biopsiesTomoaki Tanaka
International Journal of Urology : Official Journal of the Japanese Urological Association|October 12, 2019
Editorial Comment from Dr Tanaka to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasiaTomoaki Tanaka
International Journal of Urology : Official Journal of the Japanese Urological Association|June 11, 2014
Editorial comment from Dr Tanaka to Non-bladder conditions in female Taiwanese patients with interstitial cystitis/hypersensitive bladder syndromeTomoaki Tanaka
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|July 23, 2011
[Epigenetic regulation and molecular mechanisms of cellular senescence by tumor suppressor p53]Tomoaki Tanaka, Koutaro Yokote
International Journal of Urology : Official Journal of the Japanese Urological Association|January 16, 2025
Editorial comment on "Dutasteride, a 5 alpha-reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia"Tomoaki Tanaka, Akinori Minami
Journal of Human Genetics|December 9, 2016
Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitusNaoko Hashimoto, Tomoaki Tanaka
Recent Patents on Anti-Cancer Drug Discovery|May 27, 2011
New therapeutic strategies for castration-resistant prostate cancerTomoaki Tanaka, Tatsuya Nakatani
Endocrine Journal|May 28, 2025
Advancing liver metabolic zonation with single-cell and spatial omicsMasanori Fujimoto, Tomoaki Tanaka
Pageof 23